pre-miRNA Information
pre-miRNA hsa-mir-921   
Genomic Coordinates chr1: 166154743 - 166154798
Synonyms MIRN921, hsa-mir-921, MIR921
Description Homo sapiens miR-921 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-921
Sequence 2| CUAGUGAGGGACAGAACCAGGAUUC |26
Evidence Experimental
Experiments Cloned
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN31549221 11 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1464259216 3 dbSNP
rs768428855 8 dbSNP
rs746970999 20 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol SFXN4   
Synonyms BCRM1, COXPD18
Description sideroflexin 4
Transcript NM_213649   
Expression
Putative miRNA Targets on SFXN4
3'UTR of SFXN4
(miRNA target sites are highlighted)
>SFXN4|NM_213649|3'UTR
   1 GCGTGAGTTTTAGGTGAATTTATGTGGTTCCTGCTTGAAAACCTTCCCCTCTCCAGGTTCGGTTTAGAGAACTTTGCCAC
  81 AGGTCTTCTGGGGACCCCAGAGGTGTCTGTGCTGACAAGGCGACTTCAGATTCCATACTGAGATCGTTCCCAGGCTGGCG
 161 TCTCTGGGGTTTTTAAGGCTGGCTGGAGAAGACAGTGGGAGGGTGCCCCGTCTGACACCCCTGGGGTTGCTGAGGGAACG
 241 GTTGGAGTGGGGATCGGCCTGCGAAAGGATACTGTGAAATCACTAATTAACTAATAAACCTGTCTCAAGTTGAGGATTTG
 321 AAGAAAGAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' cuuaggaccaagacagggAGUGAUc 5'
                            |||||| 
Target 5' cgaaaggatactgtgaaaTCACTAa 3'
262 - 286 120.00 -10.00
2
miRNA  3' cuuAGGACCAA------GACAGGGAGUGAUc 5'
             ||||| ||      ||  ||||| | | 
Target 5' ggtTCCTGCTTGAAAACCTTCCCCTCTCCAg 3'
26 - 56 104.00 -14.50
3
miRNA  3' cuuaggaCCA-AGACAGGGAGUGAUc 5'
                 ||| |||||  || || | 
Target 5' ccccagaGGTGTCTGT-GCTGACAAg 3'
95 - 119 97.00 -12.20
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
1188485 145 ClinVar
1191001 205 ClinVar
1186555 256 ClinVar
1194864 271 ClinVar
1196188 272 ClinVar
COSN503938 2 COSMIC
COSN9027701 3 COSMIC
COSN8407170 22 COSMIC
COSN30537892 40 COSMIC
COSN510635 43 COSMIC
COSN31539140 89 COSMIC
COSN30140324 110 COSMIC
COSN19640620 129 COSMIC
COSN31578049 166 COSMIC
COSN31557095 263 COSMIC
COSN10060852 276 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs768770142 1 dbSNP
rs141886415 2 dbSNP
rs202015162 3 dbSNP
rs746422677 5 dbSNP
rs781640449 11 dbSNP
rs1348871621 15 dbSNP
rs770902326 18 dbSNP
rs1210363284 22 dbSNP
rs770540663 22 dbSNP
rs1272326364 24 dbSNP
rs746486862 27 dbSNP
rs777280264 28 dbSNP
rs757991868 46 dbSNP
rs1219537854 47 dbSNP
rs1346013845 50 dbSNP
rs1233434762 51 dbSNP
rs1481863984 53 dbSNP
rs1396302728 56 dbSNP
rs988981182 60 dbSNP
rs376186435 61 dbSNP
rs1033094479 66 dbSNP
rs1412049015 67 dbSNP
rs1329951880 68 dbSNP
rs999830828 81 dbSNP
rs1025744338 90 dbSNP
rs964341348 93 dbSNP
rs1276700090 97 dbSNP
rs1343705735 98 dbSNP
rs973022647 100 dbSNP
rs1230157988 106 dbSNP
rs1350822813 110 dbSNP
rs1307166822 116 dbSNP
rs1017516650 121 dbSNP
rs529514261 122 dbSNP
rs1197395387 125 dbSNP
rs1273367929 126 dbSNP
rs567064806 128 dbSNP
rs2275110 129 dbSNP
rs1026078580 135 dbSNP
rs1254370325 140 dbSNP
rs72832455 145 dbSNP
rs376091445 146 dbSNP
rs999923174 158 dbSNP
rs1038851809 159 dbSNP
rs941409002 160 dbSNP
rs564134430 163 dbSNP
rs905843966 165 dbSNP
rs1044697230 167 dbSNP
rs369078851 168 dbSNP
rs917442175 196 dbSNP
rs1473848805 201 dbSNP
rs530493517 203 dbSNP
rs143805954 205 dbSNP
rs1482309499 209 dbSNP
rs925759441 210 dbSNP
rs1367700160 215 dbSNP
rs561377752 216 dbSNP
rs1270577021 218 dbSNP
rs1338461553 222 dbSNP
rs978917994 225 dbSNP
rs3203943 231 dbSNP
rs142281843 234 dbSNP
rs572748734 236 dbSNP
rs749488951 239 dbSNP
rs1275913246 240 dbSNP
rs987364358 242 dbSNP
rs138956577 252 dbSNP
rs1026573156 255 dbSNP
rs115303392 256 dbSNP
rs937331850 257 dbSNP
rs927407725 262 dbSNP
rs1226293319 263 dbSNP
rs185242367 271 dbSNP
rs182079269 272 dbSNP
rs1383022559 273 dbSNP
rs1006035541 275 dbSNP
rs112915551 277 dbSNP
rs537859348 279 dbSNP
rs756647429 288 dbSNP
rs1317955200 292 dbSNP
rs1324890959 293 dbSNP
rs1449044911 295 dbSNP
rs1397981156 304 dbSNP
rs918764027 308 dbSNP
rs191496503 323 dbSNP
rs1358860718 329 dbSNP
rs555943076 330 dbSNP
rs1332266125 334 dbSNP
rs775828087 340 dbSNP
rs186202669 343 dbSNP
rs745992675 351 dbSNP
rs1352159545 352 dbSNP
rs1205169771 356 dbSNP
rs896037223 365 dbSNP
rs1053772660 367 dbSNP
rs765482563 368 dbSNP
rs912792131 371 dbSNP
rs934886636 372 dbSNP
rs567101225 376 dbSNP
rs953042764 384 dbSNP
rs781484799 385 dbSNP
rs1028635265 389 dbSNP
rs376812634 391 dbSNP
rs145133185 392 dbSNP
rs1189903825 400 dbSNP
rs1464974461 403 dbSNP
rs540008075 404 dbSNP
rs1158057406 408 dbSNP
rs1383165122 410 dbSNP
rs1206745992 413 dbSNP
rs1323226400 414 dbSNP
rs1355796880 417 dbSNP
rs1414122242 418 dbSNP
rs1290308891 419 dbSNP
rs999952187 420 dbSNP
rs7897311 421 dbSNP
rs1239209474 425 dbSNP
rs1278439870 427 dbSNP
rs1020153754 430 dbSNP
rs1281536021 435 dbSNP
rs1437311284 442 dbSNP
rs1485572822 445 dbSNP
rs987061551 453 dbSNP
rs140852391 456 dbSNP
rs1420205982 457 dbSNP
rs1181187222 473 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' cuuaggaccaagacagggAGUGAUc 5'
                            |||||| 
Target 5' cgaaaggauacugugaaaUCACUAa 3'
5 - 29
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM4903833
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_a
Location of target site NM_213649 | 3UTR | UGGAGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM4903835
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_c
Location of target site NM_213649 | 3UTR | AGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM4903837
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_b
Location of target site NM_213649 | 3UTR | AACGGUUGGAGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM4903838
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_c
Location of target site NM_213649 | 3UTR | AGUGGGAGGGUGCCCCGUCUGACACCCCUGGGGUUGCUGAGGGAACGGUUGGAGUGGGGAUCGGCCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 5 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000355697.2 | 3UTR | CCUGCGAAAGGAUACUGUGAAAUCACUAAUUAACUAAUAAACCUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE32688 Pancreatic cancer 0.325 3.5e-2 0.291 5.3e-2 32 Click to see details
GSE38974 Chronic obstructive pulmonary disease -0.268 9.8e-2 -0.210 1.6e-1 25 Click to see details
GSE19350 CNS germ cell tumors -0.349 1.3e-1 -0.238 2.3e-1 12 Click to see details
GSE28544 Breast cancer -0.197 1.8e-1 -0.160 2.3e-1 24 Click to see details
GSE38226 Liver fibrosis -0.193 2.0e-1 -0.222 1.7e-1 21 Click to see details
GSE26953 Aortic valvular endothelial cells -0.158 2.3e-1 -0.251 1.2e-1 24 Click to see details
GSE42095 Differentiated embryonic stem cells -0.157 2.4e-1 -0.201 1.8e-1 23 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis 0.162 2.5e-1 0.356 6.2e-2 20 Click to see details
GSE19536 Breast cancer 0.069 2.5e-1 0.096 1.7e-1 100 Click to see details
GSE19783 ER- ER- breast cancer 0.057 3.1e-1 0.042 3.6e-1 79 Click to see details
GSE21687 Ependynoma primary tumors 0.057 3.3e-1 0.031 4.0e-1 64 Click to see details
GSE19783 ER+ ER+ breast cancer 0.046 4.2e-1 0.099 3.4e-1 20 Click to see details
GSE28260 Renal cortex and medulla -0.041 4.5e-1 -0.198 2.6e-1 13 Click to see details
GSE28260 Renal cortex and medulla -0.041 4.5e-1 -0.198 2.6e-1 13 Click to see details
GSE28260 Renal cortex and medulla -0.041 4.5e-1 -0.198 2.6e-1 13 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
63 hsa-miR-921 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT054764 ANGPTL1 angiopoietin like 1 3 1
MIRT066171 PIP4K2C phosphatidylinositol-5-phosphate 4-kinase type 2 gamma 2 2
MIRT069409 ZFYVE21 zinc finger FYVE-type containing 21 2 8
MIRT102284 DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 2 4
MIRT107595 DNAJA1 DnaJ heat shock protein family (Hsp40) member A1 2 6
MIRT178618 HIAT1 major facilitator superfamily domain containing 14A 2 2
MIRT182407 TIPRL TOR signaling pathway regulator 2 4
MIRT186552 ZBTB18 zinc finger and BTB domain containing 18 2 2
MIRT273662 HOXC8 homeobox C8 2 2
MIRT283191 C16ORF52 chromosome 16 open reading frame 52 2 2
MIRT284890 NFAT5 nuclear factor of activated T-cells 5 2 2
MIRT347670 LSM14A LSM14A, mRNA processing body assembly factor 2 2
MIRT400222 SLC35F6 solute carrier family 35 member F6 2 2
MIRT403517 ASPH aspartate beta-hydroxylase 2 2
MIRT442251 DCTN5 dynactin subunit 5 2 2
MIRT443023 SDR39U1 short chain dehydrogenase/reductase family 39U member 1 2 2
MIRT443097 RNF20 ring finger protein 20 2 2
MIRT444560 TRA2B transformer 2 beta homolog 2 2
MIRT445696 PRKG1 protein kinase, cGMP-dependent, type I 2 2
MIRT454084 TMEM209 transmembrane protein 209 2 2
MIRT455463 LYPLA2 lysophospholipase II 2 2
MIRT456653 TIFA TRAF interacting protein with forkhead associated domain 2 2
MIRT458147 LYRM4 LYR motif containing 4 2 6
MIRT467073 SRRD SRR1 domain containing 2 4
MIRT467245 SPPL2A signal peptide peptidase like 2A 2 2
MIRT468246 SFXN4 sideroflexin 4 2 2
MIRT471589 PAQR5 progestin and adipoQ receptor family member 5 2 19
MIRT476639 G2E3 G2/M-phase specific E3 ubiquitin protein ligase 2 2
MIRT482433 ADM adrenomedullin 2 10
MIRT486848 PERP PERP, TP53 apoptosis effector 2 6
MIRT489656 SHMT1 serine hydroxymethyltransferase 1 2 2
MIRT493441 KANSL1 KAT8 regulatory NSL complex subunit 1 2 6
MIRT493841 FOXN3 forkhead box N3 2 4
MIRT501378 RBFOX2 RNA binding protein, fox-1 homolog 2 2 10
MIRT509679 ATAD5 ATPase family, AAA domain containing 5 2 4
MIRT510280 MED28 mediator complex subunit 28 2 2
MIRT512221 ATXN3 ataxin 3 2 6
MIRT514030 BNIP2 BCL2 interacting protein 2 2 2
MIRT521375 RDX radixin 2 4
MIRT521444 RAD51 RAD51 recombinase 2 2
MIRT526055 CBR1 carbonyl reductase 1 2 2
MIRT528658 FUNDC2 FUN14 domain containing 2 2 2
MIRT529975 TNFAIP8L1 TNF alpha induced protein 8 like 1 2 2
MIRT544098 IPMK inositol polyphosphate multikinase 2 2
MIRT545579 SNRPA1 small nuclear ribonucleoprotein polypeptide A' 2 2
MIRT547424 MED4 mediator complex subunit 4 2 2
MIRT548955 CD2AP CD2 associated protein 2 2
MIRT549537 NDUFA6 NADH:ubiquinone oxidoreductase subunit A6 2 4
MIRT552550 ZFP36L2 ZFP36 ring finger protein like 2 2 4
MIRT554640 ROBO1 roundabout guidance receptor 1 2 2
MIRT564904 YTHDF1 YTH N6-methyladenosine RNA binding protein 1 2 2
MIRT565578 SLC6A8 solute carrier family 6 member 8 2 2
MIRT568312 BAG4 BCL2 associated athanogene 4 2 2
MIRT617891 PTCHD3 patched domain containing 3 2 2
MIRT621892 TAF13 TATA-box binding protein associated factor 13 2 2
MIRT642850 RNF135 ring finger protein 135 2 2
MIRT665395 WEE1 WEE1 G2 checkpoint kinase 2 2
MIRT697879 UBE2B ubiquitin conjugating enzyme E2 B 2 2
MIRT698492 THOC2 THO complex 2 2 2
MIRT701227 OCRL OCRL, inositol polyphosphate-5-phosphatase 2 2
MIRT701872 MPLKIP M-phase specific PLK1 interacting protein 2 2
MIRT707045 TRPV2 transient receptor potential cation channel subfamily V member 2 2 2
MIRT715216 NPVF neuropeptide VF precursor 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-921 Progesterone approved 5994 Microarray Breast cancer 22330642 2012 up-regulated
miR-921 5-Fluorouracil approved 3385 Microarray CNE cells 22614822 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-921 Fluorouracil 3385 NSC19893 approved sensitive High Pancreatic Cancer cell line (PANC-1)
hsa-miR-921 Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (PANC-1)
hsa-miR-921 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-921 Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (AsPC-1)
hsa-mir-921 Dabrafenib 44462760 NSC764134 approved sensitive cell line (A375)
hsa-mir-921 Androstenedione+Anastrozole resistant cell line (MCF-7)
hsa-mir-921 Cisplatin 5460033 NSC119875 approved sensitive cell line (KYSE)
hsa-mir-921 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-miR-921 Temozolomide 5394 NSC362856 approved sensitive cell line (U251)
hsa-miR-921 Doxorubicin 31703 NSC123127 approved resistant cell line (HS578T)
hsa-miR-921 Osimertinib 71496458 NSC779217 approved resistant cell line (H1975)
hsa-miR-921 4-Hydroxytamoxifen+Tamoxifen resistant cell line (LY2)
hsa-miR-921 Ethanol+Tamoxifen resistant cell line (LY2)
hsa-miR-921 Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-921 Sunitinib 5329102 NSC750690 approved resistant tissue (CardB)
hsa-miR-921 Pegylated interferon alpha+Ribavirin sensitive tissue (chronic hepatitis C)
hsa-miR-921 Oxaliplatin 6857599 NSC266046 approved resistant cell line (IGROV-1)
hsa-miR-921 Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-921 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-921 Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-921 Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR1)
hsa-miR-921 Gemcitabine 60750 NSC613327 approved resistant cell line (Panc1-GR4)

Error report submission